Policy and Ethics

Ten Questions for Westminster: A CRISPR Briefing for People Who Write the Rules

Parliamentary staff, civil servants and local health leaders are increasingly asked to make judgements about gene editing without a scientific background. Here are ten questions worth being able to answer, each with a short briefing note.

Nov 8, 2026

The Three-Parent Precedent: What Mitochondrial Donation Teaches Britain About Heritable CRISPR

Britain is one of the few countries that already permits a heritable genetic intervention in clinical treatment. That fact rarely features in debates about heritable genome editing, and it should. The mitochondrial donation framework shows what cautious regulation can achieve — and where its logic would strain under CRISPR.

Nov 8, 2026